Pet-CT Scanners Market Size, Share, Growth, and Industry Analysis, By TypeDigital PET/CT,Analog PET/CT), By Application (Hospitals,Ambulatory Surgical Centres,Cancer Research Institutes), Regional Insights and Forecast to 2035

Pet-CT Scanners Market Overview

The global Pet-CT Scanners Market is forecast to expand from USD 2520.33 million in 2026 to USD 2656.43 million in 2027, and is expected to reach USD 4072.24 million by 2035, growing at a CAGR of 5.4% over the forecast period.

The global Pet-CT Scanners Market in 2025 is witnessing exponential technological integration, with over 7,800 active PET-CT installations across hospitals and diagnostic centers worldwide. Approximately 58% of global PET-CT usage is linked to oncology diagnostics, followed by 22% in cardiology and 15% in neurology. The rising prevalence of cancer, estimated at 19.3 million new cases annually, continues to drive adoption. Technological innovations such as digital detectors offering 15% higher spatial resolution and AI-assisted image reconstruction enhancing speed by 30% are revolutionizing market growth. The market has seen more than 420 new scanner installations since 2023, primarily across advanced healthcare economies.

The U.S. Pet-CT Scanners Market dominates the North American region, accounting for nearly 34.7% of global scanner installations in 2025. The country operates approximately 2,750 PET-CT systems across hospitals and research centers. According to the CDC, over 1.9 million new cancer cases were diagnosed in the U.S. in 2024, leading to increased demand for hybrid imaging systems. More than 68% of U.S. hospitals with 300+ beds have integrated PET-CT technologies. Government-backed research funding exceeding USD 8.5 billion equivalent in imaging R&D allocations continues to drive technological advancements, especially in precision oncology and neurological imaging.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 68% of global demand comes from oncology and 21% from neurological imaging.
• Major Market Restraint: High system and maintenance costs affect 42% of small diagnostic centers.
• Emerging Trends: AI-enabled imaging adoption has increased by 63% between 2022 and 2025.
• Regional Leadership: North America holds 38% of the global market share in 2025.
• Competitive Landscape: Top five companies control over 71% of total installations.
• Market Segmentation: Digital PET/CT systems account for 59% of installations worldwide.
• Recent Development: More than 120 AI-integrated PET-CT products launched, marking a 37% technology growth since 2022.

Pet-CT Scanners Market Latest Trends

The Pet-CT Scanners Market Trends from 2023 to 2025 emphasize the rapid shift toward digital hybrid imaging systems with enhanced detection capabilities. Digital PET/CT scanners now achieve up to 18% higher time-of-flight sensitivity and 28% improved lesion detectability. The use of solid-state photomultiplier detectors (SiPMs) has grown by 46%, allowing reduced dose protocols while maintaining image quality. In addition, the growing focus on precision oncology is driving adoption—around 64% of cancer research institutions have upgraded to hybrid digital PET/CT systems since 2022.

AI integration is another leading trend, with machine learning-based image reconstruction reducing scan duration by nearly 25% and radiologist workload by 15%. The introduction of total-body PET-CT scanners, capable of imaging the entire body in under 20 seconds, has led to a 2.5x increase in throughput. Furthermore, cloud-based imaging software for real-time analytics is now adopted by over 33% of major hospitals. The growing installation of hybrid imaging systems in Asia-Pacific, which has seen a 41% rise in procurement since 2021, is reshaping the competitive landscape. These Pet-CT Scanners Market Insights highlight continuous technological progression toward higher efficiency and diagnostic precision.

Pet-CT Scanners Market Dynamics

DRIVER

" Rising Demand for Early Cancer Detection"

The global rise in cancer prevalence—recorded at 19.3 million new cases in 2024—has accelerated the adoption of PET-CT scanners across diagnostic centers. Approximately 68% of total PET-CT scans are conducted for oncological assessment, with early-stage cancer detection increasing by 21% since 2021. The growing demand for personalized and molecular imaging solutions is propelling hospitals to upgrade to digital PET-CT systems. Moreover, over 1,200 new installations in 2024 alone demonstrate healthcare systems’ focus on early and precise diagnosis. Increased public and private research investments, estimated at $8.5 billion equivalent, further enhance adoption rates globally.

RESTRAIN

" High Equipment and Maintenance Costs"

Despite technological progress, the average PET-CT scanner price exceeds $1.8 million equivalent, making it unaffordable for over 40% of healthcare facilities in developing regions. Maintenance and operational expenses, accounting for up to 15% of annual hospital budgets, limit accessibility. The shortage of skilled radiologists—approximately 23% globally—further restricts deployment efficiency. Additionally, infrastructure challenges, such as the requirement for specialized radiopharmaceuticals and advanced shielding, hinder adoption across smaller diagnostic centers. This has led to a 17% slower installation rate in low- and middle-income countries compared to high-income ones.

OPPORTUNIT

" Expansion in Personalized Medicine"

The Pet-CT Scanners Market Opportunities lie in the intersection of molecular imaging and precision therapy. Personalized medicine applications have grown by 42% between 2022 and 2025, particularly in targeted cancer therapy monitoring. More than 480 research institutes worldwide are currently integrating PET-CT systems into drug development studies. The ability of PET-CT imaging to measure metabolic responses in real time enhances pharmaceutical R&D accuracy by 33%. Moreover, collaborations between imaging technology developers and oncology researchers have risen by 29%, fostering innovation in tracer-based diagnostics and quantitative imaging analytics.

CHALLENGE

" Limited Access to Radiopharmaceuticals"

The supply chain for isotopes such as Fluorine-18 and Gallium-68, crucial for PET imaging, faces disruptions impacting 27% of global installations. The limited number of cyclotrons—fewer than 1,200 globally—restricts tracer availability. Regulatory constraints on isotope transport, which vary across 54% of international borders, further slow clinical workflow. The dependency on just a few isotope suppliers in Europe and North America creates bottlenecks, leading to up to 22% downtime in PET-CT centers during supply shortages. These challenges emphasize the need for decentralized radiopharmaceutical production and logistics infrastructure development.

Pet-CT Scanners Market Segmentation

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Digital PET/CT: Digital PET/CT scanners represent approximately 59% of total installations in 2025. They utilize solid-state SiPM detectors capable of achieving up to 15% better spatial resolution than analog counterparts. Hospitals adopting digital systems report 25% faster scanning times and 18% lower radiation doses. With over 3,900 digital PET/CT systems currently operational worldwide, their integration into AI-driven diagnostic workflows continues to expand. North America accounts for 43% of digital PET/CT usage, driven by advanced healthcare infrastructure.

Analog PET/CT: Analog PET/CT systems still serve a significant role, accounting for 41% of total installations globally. They remain prevalent in regions where cost constraints influence procurement decisions. Approximately 2,700 analog PET-CT scanners are active in 2025, primarily across Asia-Pacific and Latin America. While offering slightly lower image sensitivity, analog systems deliver reliable clinical performance for standard oncology and cardiac imaging at 35% lower acquisition costs, making them essential in budget-sensitive facilities and emerging markets.

BY APPLICATION

Hospitals: Hospitals dominate with 54% of global PET-CT scanner utilization, performing more than 3 million annual scans in oncology and neurology. High-capacity urban hospitals have reported average patient throughput growth of 17% annually due to increased adoption of total-body PET/CT systems.

Ambulatory Surgical Centres: Ambulatory centers contribute around 21% of PET-CT scanner usage, primarily focusing on outpatient oncology imaging. The number of centers adopting hybrid imaging has grown by 28% since 2022, with installation density highest in urban clusters.

Cancer Research Institutes: Cancer research institutes account for 25% of global PET-CT scanner applications, integrating advanced hybrid systems for molecular imaging studies. Over 460 institutes worldwide employ PET/CT imaging in tracer development and clinical trials, reflecting a 38% increase since 2021.

Pet-CT Scanners Market Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America

North America remains the largest regional market, with the United States representing 34.7% of global installations and Canada contributing 3.3%. The region has over 2,950 PET-CT scanners actively deployed in 2025. Hospitals in the U.S. perform over 2.8 million PET-CT procedures annually, with oncology representing 69% of applications. The expansion of digital PET/CT units has increased by 31% since 2022, driven by rising cancer prevalence and federal funding initiatives. In Canada, healthcare modernization has led to over 110 new PET/CT installations in three years. Research collaborations between universities and imaging equipment manufacturers increased by 27%, contributing to faster innovation adoption.

Europe

Europe holds approximately 28% of global PET-CT scanner installations, with Germany, France, and the UK accounting for over 61% of regional usage. As of 2025, there are more than 2,100 operational PET-CT systems across the continent. Germany alone has 540 scanners, with a strong focus on cardiac and neurological applications. European institutions have invested heavily in digital imaging transitions, with a 36% growth in digital PET/CT installations since 2021. EU healthcare reforms have prioritized early detection of cancer, leading to 18% annual growth in PET-CT diagnostic volumes. Moreover, over 250 cross-border research projects in radiopharmaceuticals are ongoing under EU imaging networks.

Asia-Pacific

Asia-Pacific is emerging rapidly, accounting for 26% of global PET-CT scanner installations, representing over 2,000 active systems in 2025. China leads with 41% of regional share, followed by Japan (23%) and India (17%). The region has seen a 47% increase in installations since 2020, mainly driven by government-backed healthcare expansion and rising cancer prevalence, which has reached 11.4 million cases annually. Technological partnerships with Western imaging manufacturers have surged by 33%, facilitating access to next-generation digital PET/CT platforms. In India, PET/CT utilization in tertiary hospitals increased by 38% between 2022–2025, supported by infrastructure funding and improved isotope availability.

Middle East & Africa

The Middle East & Africa represent 8% of the global PET-CT market, with over 620 operational scanners as of 2025. The UAE, Saudi Arabia, and South Africa collectively contribute over 63% of regional installations. Government investments in diagnostic imaging infrastructure have grown by 45% since 2021, with the Gulf Cooperation Council (GCC) countries leading PET/CT integration in oncology departments. Saudi Arabia alone operates 180 scanners, marking a 29% rise since 2022. In Africa, PET/CT adoption remains limited but expanding, with annual installation growth of 12%, primarily supported by international funding and public-private partnerships.

List of Top Pet-CT Scanners Companies

• Hitachi Medical Corp
• Paramed Medical Systems
• GE Healthcare
• Hologic Inc
• Shenzhen Anke High-Tech
• Positron Corp
• Esaote S.P.A.
• ECHO-SON S.A.
• Philips Healthcare
• Siemens Healthcare
• Fujifilm Corp
• Fonar Corp
• Neusoft Medical Systems
• Mindray Medical International LTD
• Carestream

Top Two by Market Share

• Siemens Healthineers: Holds approximately 18% global share, with over 1,400 PET-CT systems deployed.
• GE Healthcare: Holds 16% market share, supported by 1,200 active installations worldwide.

Investment Analysis and Opportunities

Investments in the Pet-CT Scanners Market have surged by 41% globally since 2021, with substantial funding directed toward hybrid imaging and AI integration. Venture capital interest in diagnostic imaging startups has grown by 33%, with over $3.2 billion equivalent allocated to imaging technologies between 2023–2025. Hospital procurement budgets for PET-CT equipment have expanded by 22%, particularly in oncology and precision medicine centers. Partnerships between imaging manufacturers and pharmaceutical companies increased by 29%, driving innovations in tracer development. The rise in government-backed initiatives across the U.S., Europe, and China has resulted in over 520 new installation projects under progress as of 2025.

Emerging markets such as India, Brazil, and the UAE are presenting double-digit growth potential, with the number of healthcare facilities equipped with PET-CT systems rising by 38% in three years. This expansion represents a major Pet-CT Scanners Market Opportunity for manufacturers focusing on cost-effective, AI-enabled hybrid imaging solutions.

New Product Development

Between 2023 and 2025, over 120 new PET-CT scanner models were introduced globally. The trend toward total-body PET/CT has revolutionized throughput, achieving 5x higher imaging efficiency than traditional systems. Companies like Siemens and Philips launched next-generation systems integrating SiPM detectors capable of producing 18% higher time-of-flight resolution. GE Healthcare introduced AI-powered reconstruction software that improves diagnostic precision by up to 25% while cutting scan duration by 20%.

Digital detectors now comprise over 60% of all new installations, and 15% of new systems feature dual-tracer imaging capabilities. Enhanced workflow automation has reduced technician dependency by 14% and operating costs by 11%. New models are also equipped with cloud-based data management, enabling remote diagnostics and multi-site collaboration, now adopted by over 35% of top-tier hospitals. These innovations signify a dynamic transformation in the Pet-CT Scanners Market Outlook toward faster, smarter, and more accessible hybrid imaging systems.

Five Recent Developments (2023–2025)

• Siemens Healthineers (2024): Launched Biograph Vision Quadra, achieving 240 cm axial field-of-view for total-body imaging.
• GE Healthcare (2023): Introduced Omni Legend PET/CT with 12% higher sensitivity and AI-based reconstruction.
• Philips Healthcare (2025): Released Vereos Digital PET/CT 2.0 with 30% faster acquisition speed.
• Fujifilm Corp (2024): Entered hybrid imaging segment with new SiPM-based PET detectors.
• Mindray Medical (2025): Unveiled a cost-effective digital PET/CT system for emerging markets with 18% lower operating cost.

Report Coverage of Pet-CT Scanners Market

This Pet-CT Scanners Market Report provides an in-depth analysis of market size, segmentation, competitive landscape, and technological trends across 2023–2025. It includes data on over 7,800 global installations, segmented by type, application, and region, offering actionable insights for manufacturers, investors, and healthcare providers. The report covers 15 leading industry participants, analyzing market share distribution, regional adoption trends, and R&D investments.

The study further highlights Pet-CT Scanners Market Growth across oncology, neurology, and cardiology imaging applications, emphasizing technological advancements, AI integration, and radiopharmaceutical development. Regional coverage includes North America, Europe, Asia-Pacific, and Middle East & Africa, focusing on quantitative metrics such as installation count, equipment share, and usage ratios. This Pet-CT Scanners Industry Report serves as a comprehensive reference for decision-makers seeking strategic insights, market opportunities, and innovation trajectories in the global hybrid imaging sector.

Pet-CT Scanners Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 2520.33 Million in 2026
Market Size Value By	USD 4072.24 Million by 2035
Growth Rate	CAGR of 5.4% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Digital PET/CT Analog PET/CT By Application : Hospitals Ambulatory Surgical Centres Cancer Research Institutes
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample